[unable to retrieve full-text content]France is handing out third shots of the two-dose vaccines to cancer patients and others with immune system impairments. In the United States, patients like these are on their own. NYT > Well
A Danish study with data on people diagnosed with HIV between 1985 and 2017 shows dramatic declines in death rates over the course of the HIV epidemic. In the years since 2006, the mortality of people living with HIV who survived their first two years after HIV diagnosis was close to that of the general… Read More »
Breadcrumb Trail Links News Health Canada The changes seem to underline the political sensitivities around Canada’s painfully slow vaccine rollout, where the hint of queue jumping is quickly snuffed out Author of the article: Tom Blackwell Publishing date: Mar 31, 2021 • 3 days ago • 4 minute read • 24 Comments North York General Hospital.… Read More »
More Americans are happier in March 2021 than they’ve been for a year, based on consumer research from Civic Science polling U.S. adults in early March 2021. For the first time, a larger percent of Americans said they were better off financially since the start of the pandemic. This week, Civic Science shared their latest data… Read More »
People with HIV who already have resistance to a non-nucleoside reverse transcriptase inhibitor (NNRTI) when they start first-line antiretroviral treatment containing the integrase inhibitor dolutegravir were less likely to achieve viral suppression, a large clinical trial in South Africa has reported. NNRTI resistance has not been shown to affect responses to dolutegravir-based treatment previously. The… Read More »
A US study has concluded that weight gain is greater by around 2 to 4 kg in HIV-positive people taking bictegravir or dolutegravir as part of their first antiretroviral therapy (ART), compared to their counterparts using other drug regimens. A similar effect was reported in those using the protease inhibitor darunavir. The study led by… Read More »